Global CEACAM1Antibody Production, Demand and Key Producers, 2022-2028
CEACAM1 Antibody is an unconjugated antibody to CEACAM1.
This report studies the global CEACAM1Antibody production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for CEACAM1Antibody, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of CEACAM1Antibody that contribute to its increasing demand across many markets.
The global CEACAM1Antibody market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global CEACAM1Antibody total production and demand, 2017-2028, (K Units)
Global CEACAM1Antibody total production value, 2017-2028, (USD Million)
Global CEACAM1Antibody production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global CEACAM1Antibody consumption by region & country, CAGR, 2017-2028 & (K Units)
U.S. VS China: CEACAM1Antibody domestic production, consumption, key domestic manufacturers and share
Global CEACAM1Antibody production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)
Global CEACAM1Antibody production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global CEACAM1Antibody production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)
This reports profiles key players in the global CEACAM1Antibody market based on the following parameters – headquarters, production locations, products portfolio, CEACAM1Antibody revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World CEACAM1Antibody market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global CEACAM1Antibody Market, By Region:
1. How big is the global CEACAM1Antibody market?
2. What is the demand of the global CEACAM1Antibody market?
3. What is the year over year growth of the global CEACAM1Antibody market?
4. What is the production and production value of the global CEACAM1Antibody market?
5. Who are the key producers in the global CEACAM1Antibody market?
6. What are the growth factors driving the market demand?
This report studies the global CEACAM1Antibody production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for CEACAM1Antibody, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of CEACAM1Antibody that contribute to its increasing demand across many markets.
The global CEACAM1Antibody market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global CEACAM1Antibody total production and demand, 2017-2028, (K Units)
Global CEACAM1Antibody total production value, 2017-2028, (USD Million)
Global CEACAM1Antibody production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global CEACAM1Antibody consumption by region & country, CAGR, 2017-2028 & (K Units)
U.S. VS China: CEACAM1Antibody domestic production, consumption, key domestic manufacturers and share
Global CEACAM1Antibody production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)
Global CEACAM1Antibody production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global CEACAM1Antibody production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)
This reports profiles key players in the global CEACAM1Antibody market based on the following parameters – headquarters, production locations, products portfolio, CEACAM1Antibody revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World CEACAM1Antibody market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global CEACAM1Antibody Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Monoclonal Antibody
- Polyclonal Antibody
- Flow Cytometry
- ELISA
- Western Blot
- Immunoprecipitation
- Immunofluorescence
- Other
- Sino Biological, Inc.
- ??Abcam
- Thermo Fisher Scientific (China) Co., Ltd.
- Bio-Techne
- BioLegend
- LifeSpan BioSciences, Inc
- Elabscience Biotechnology Inc.
- Boster Biological Technology
- Merck
- Wuhan Fine Biotech Co., Ltd.
- ProSci Incorporated
- Abbexa
1. How big is the global CEACAM1Antibody market?
2. What is the demand of the global CEACAM1Antibody market?
3. What is the year over year growth of the global CEACAM1Antibody market?
4. What is the production and production value of the global CEACAM1Antibody market?
5. Who are the key producers in the global CEACAM1Antibody market?
6. What are the growth factors driving the market demand?
'@LOT1 SUPPLY SUMMARY
1.1 CEACAM1Antibody Introduction
1.2 World CEACAM1Antibody Supply & Forecast
1.2.1 World CEACAM1Antibody Production Value (2017 & 2021 & 2028)
1.2.2 World CEACAM1Antibody Production (2017-2028)
1.2.3 World CEACAM1Antibody Pricing Trends (2017-2028)
1.3 World CEACAM1Antibody Production by Region
1.3.1 World CEACAM1Antibody Production Value by Region (2017-2028)
1.3.2 World CEACAM1Antibody Production by Region (2017-2028)
1.3.3 World CEACAM1Antibody Average Price by Region (2017-2028)
1.3.4 North America CEACAM1Antibody Production (2017-2028)
1.3.5 Europe CEACAM1Antibody Production (2017-2028)
1.3.6 China CEACAM1Antibody Production (2017-2028)
1.3.7 Japan CEACAM1Antibody Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 CEACAM1Antibody Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 CEACAM1Antibody Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World CEACAM1Antibody Demand (2017-2028)
2.2 World CEACAM1Antibody Consumption by Region
2.2.1 World CEACAM1Antibody Consumption by Region (2017-2022)
2.2.2 World CEACAM1Antibody Consumption Forecast by Region (2023-2028)
2.3 United States CEACAM1Antibody Consumption (2017-2028)
2.4 China CEACAM1Antibody Consumption (2017-2028)
2.5 Europe CEACAM1Antibody Consumption (2017-2028)
2.6 Japan CEACAM1Antibody Consumption (2017-2028)
2.7 South Korea CEACAM1Antibody Consumption (2017-2028)
2.8 ASEAN CEACAM1Antibody Consumption (2017-2028)
2.9 India CEACAM1Antibody Consumption (2017-2028)
3 WORLD CEACAM1ANTIBODY MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World CEACAM1Antibody Production Value by Manufacturer (2017-2022)
3.2 World CEACAM1Antibody Production by Manufacturer (2017-2022)
3.3 World CEACAM1Antibody Average Price by Manufacturer (2017-2022)
3.4 CEACAM1Antibody Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global CEACAM1Antibody Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for CEACAM1Antibody in 2021
3.5.3 Global Concentration Ratios (CR8) for CEACAM1Antibody in 2021
3.6 CEACAM1Antibody Market: Overall Company Footprint Analysis
3.6.1 CEACAM1Antibody Market: Region Footprint
3.6.2 CEACAM1Antibody Market: Company Product Type Footprint
3.6.3 CEACAM1Antibody Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: CEACAM1Antibody Production Value Comparison
4.1.1 United States VS China: CEACAM1Antibody Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: CEACAM1Antibody Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: CEACAM1Antibody Production Comparison
4.2.1 United States VS China: CEACAM1Antibody Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: CEACAM1Antibody Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: CEACAM1Antibody Consumption Comparison
4.3.1 United States VS China: CEACAM1Antibody Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: CEACAM1Antibody Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States CEACAM1Antibody Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of CEACAM1Antibody in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States CEACAM1Antibody Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States CEACAM1Antibody Production by Domestic Manufacturer, (2017-2022)
4.5 China CEACAM1Antibody Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of CEACAM1Antibody in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China CEACAM1Antibody Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China CEACAM1Antibody Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World CEACAM1Antibody Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of CEACAM1Antibody in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World CEACAM1Antibody Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World CEACAM1Antibody Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World CEACAM1Antibody Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 Monoclonal Antibody
5.2.2 Polyclonal Antibody
5.3 Market Segment by Type
5.3.1 World CEACAM1Antibody Production by Type (2017-2028)
5.3.2 World CEACAM1Antibody Production Value by Type (2017-2028)
5.3.3 World CEACAM1Antibody Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World CEACAM1Antibody Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Flow Cytometry
6.2.2 ELISA
6.2.3 Western Blot
6.2.4 Immunoprecipitation
6.2.5 Immunofluorescence
6.2.6 Other
6.3 Market Segment by Application
6.3.1 World CEACAM1Antibody Production by Application (2017-2028)
6.3.2 World CEACAM1Antibody Production Value by Application (2017-2028)
6.3.3 World CEACAM1Antibody Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 Sino Biological, Inc.
7.1.1 Sino Biological, Inc. Details
7.1.2 Sino Biological, Inc. Major Business
7.1.3 Sino Biological, Inc. CEACAM1Antibody Product and Services
7.1.4 Sino Biological, Inc. CEACAM1Antibody Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 Sino Biological, Inc. Recent Developments/Updates
7.1.6 Sino Biological, Inc. Competitive Strengths & Weaknesses
7.2 ??Abcam
7.2.1 ??Abcam Details
7.2.2 ??Abcam Major Business
7.2.3 ??Abcam CEACAM1Antibody Product and Services
7.2.4 ??Abcam CEACAM1Antibody Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 ??Abcam Recent Developments/Updates
7.2.6 ??Abcam Competitive Strengths & Weaknesses
7.3 Thermo Fisher Scientific (China) Co., Ltd.
7.3.1 Thermo Fisher Scientific (China) Co., Ltd. Details
7.3.2 Thermo Fisher Scientific (China) Co., Ltd. Major Business
7.3.3 Thermo Fisher Scientific (China) Co., Ltd. CEACAM1Antibody Product and Services
7.3.4 Thermo Fisher Scientific (China) Co., Ltd. CEACAM1Antibody Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 Thermo Fisher Scientific (China) Co., Ltd. Recent Developments/Updates
7.3.6 Thermo Fisher Scientific (China) Co., Ltd. Competitive Strengths & Weaknesses
7.4 Bio-Techne
7.4.1 Bio-Techne Details
7.4.2 Bio-Techne Major Business
7.4.3 Bio-Techne CEACAM1Antibody Product and Services
7.4.4 Bio-Techne CEACAM1Antibody Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Bio-Techne Recent Developments/Updates
7.4.6 Bio-Techne Competitive Strengths & Weaknesses
7.5 BioLegend
7.5.1 BioLegend Details
7.5.2 BioLegend Major Business
7.5.3 BioLegend CEACAM1Antibody Product and Services
7.5.4 BioLegend CEACAM1Antibody Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 BioLegend Recent Developments/Updates
7.5.6 BioLegend Competitive Strengths & Weaknesses
7.6 LifeSpan BioSciences, Inc
7.6.1 LifeSpan BioSciences, Inc Details
7.6.2 LifeSpan BioSciences, Inc Major Business
7.6.3 LifeSpan BioSciences, Inc CEACAM1Antibody Product and Services
7.6.4 LifeSpan BioSciences, Inc CEACAM1Antibody Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 LifeSpan BioSciences, Inc Recent Developments/Updates
7.6.6 LifeSpan BioSciences, Inc Competitive Strengths & Weaknesses
7.7 Elabscience Biotechnology Inc.
7.7.1 Elabscience Biotechnology Inc. Details
7.7.2 Elabscience Biotechnology Inc. Major Business
7.7.3 Elabscience Biotechnology Inc. CEACAM1Antibody Product and Services
7.7.4 Elabscience Biotechnology Inc. CEACAM1Antibody Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 Elabscience Biotechnology Inc. Recent Developments/Updates
7.7.6 Elabscience Biotechnology Inc. Competitive Strengths & Weaknesses
7.8 Boster Biological Technology
7.8.1 Boster Biological Technology Details
7.8.2 Boster Biological Technology Major Business
7.8.3 Boster Biological Technology CEACAM1Antibody Product and Services
7.8.4 Boster Biological Technology CEACAM1Antibody Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 Boster Biological Technology Recent Developments/Updates
7.8.6 Boster Biological Technology Competitive Strengths & Weaknesses
7.9 Merck
7.9.1 Merck Details
7.9.2 Merck Major Business
7.9.3 Merck CEACAM1Antibody Product and Services
7.9.4 Merck CEACAM1Antibody Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.9.5 Merck Recent Developments/Updates
7.9.6 Merck Competitive Strengths & Weaknesses
7.10 Wuhan Fine Biotech Co., Ltd.
7.10.1 Wuhan Fine Biotech Co., Ltd. Details
7.10.2 Wuhan Fine Biotech Co., Ltd. Major Business
7.10.3 Wuhan Fine Biotech Co., Ltd. CEACAM1Antibody Product and Services
7.10.4 Wuhan Fine Biotech Co., Ltd. CEACAM1Antibody Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.10.5 Wuhan Fine Biotech Co., Ltd. Recent Developments/Updates
7.10.6 Wuhan Fine Biotech Co., Ltd. Competitive Strengths & Weaknesses
7.11 ProSci Incorporated
7.11.1 ProSci Incorporated Details
7.11.2 ProSci Incorporated Major Business
7.11.3 ProSci Incorporated CEACAM1Antibody Product and Services
7.11.4 ProSci Incorporated CEACAM1Antibody Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.11.5 ProSci Incorporated Recent Developments/Updates
7.11.6 ProSci Incorporated Competitive Strengths & Weaknesses
7.12 Abbexa
7.12.1 Abbexa Details
7.12.2 Abbexa Major Business
7.12.3 Abbexa CEACAM1Antibody Product and Services
7.12.4 Abbexa CEACAM1Antibody Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.12.5 Abbexa Recent Developments/Updates
7.12.6 Abbexa Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of CEACAM1Antibody and Key Manufacturers
8.2 CEACAM1Antibody Manufacturing Costs
8.3 CEACAM1Antibody Production Process
8.4 CEACAM1Antibody Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for CEACAM1Antibody Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 CEACAM1Antibody Typical Distributors
9.3 CEACAM1Antibody Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
1.1 CEACAM1Antibody Introduction
1.2 World CEACAM1Antibody Supply & Forecast
1.2.1 World CEACAM1Antibody Production Value (2017 & 2021 & 2028)
1.2.2 World CEACAM1Antibody Production (2017-2028)
1.2.3 World CEACAM1Antibody Pricing Trends (2017-2028)
1.3 World CEACAM1Antibody Production by Region
1.3.1 World CEACAM1Antibody Production Value by Region (2017-2028)
1.3.2 World CEACAM1Antibody Production by Region (2017-2028)
1.3.3 World CEACAM1Antibody Average Price by Region (2017-2028)
1.3.4 North America CEACAM1Antibody Production (2017-2028)
1.3.5 Europe CEACAM1Antibody Production (2017-2028)
1.3.6 China CEACAM1Antibody Production (2017-2028)
1.3.7 Japan CEACAM1Antibody Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 CEACAM1Antibody Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 CEACAM1Antibody Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World CEACAM1Antibody Demand (2017-2028)
2.2 World CEACAM1Antibody Consumption by Region
2.2.1 World CEACAM1Antibody Consumption by Region (2017-2022)
2.2.2 World CEACAM1Antibody Consumption Forecast by Region (2023-2028)
2.3 United States CEACAM1Antibody Consumption (2017-2028)
2.4 China CEACAM1Antibody Consumption (2017-2028)
2.5 Europe CEACAM1Antibody Consumption (2017-2028)
2.6 Japan CEACAM1Antibody Consumption (2017-2028)
2.7 South Korea CEACAM1Antibody Consumption (2017-2028)
2.8 ASEAN CEACAM1Antibody Consumption (2017-2028)
2.9 India CEACAM1Antibody Consumption (2017-2028)
3 WORLD CEACAM1ANTIBODY MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World CEACAM1Antibody Production Value by Manufacturer (2017-2022)
3.2 World CEACAM1Antibody Production by Manufacturer (2017-2022)
3.3 World CEACAM1Antibody Average Price by Manufacturer (2017-2022)
3.4 CEACAM1Antibody Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global CEACAM1Antibody Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for CEACAM1Antibody in 2021
3.5.3 Global Concentration Ratios (CR8) for CEACAM1Antibody in 2021
3.6 CEACAM1Antibody Market: Overall Company Footprint Analysis
3.6.1 CEACAM1Antibody Market: Region Footprint
3.6.2 CEACAM1Antibody Market: Company Product Type Footprint
3.6.3 CEACAM1Antibody Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: CEACAM1Antibody Production Value Comparison
4.1.1 United States VS China: CEACAM1Antibody Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: CEACAM1Antibody Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: CEACAM1Antibody Production Comparison
4.2.1 United States VS China: CEACAM1Antibody Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: CEACAM1Antibody Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: CEACAM1Antibody Consumption Comparison
4.3.1 United States VS China: CEACAM1Antibody Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: CEACAM1Antibody Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States CEACAM1Antibody Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of CEACAM1Antibody in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States CEACAM1Antibody Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States CEACAM1Antibody Production by Domestic Manufacturer, (2017-2022)
4.5 China CEACAM1Antibody Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of CEACAM1Antibody in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China CEACAM1Antibody Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China CEACAM1Antibody Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World CEACAM1Antibody Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of CEACAM1Antibody in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World CEACAM1Antibody Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World CEACAM1Antibody Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World CEACAM1Antibody Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 Monoclonal Antibody
5.2.2 Polyclonal Antibody
5.3 Market Segment by Type
5.3.1 World CEACAM1Antibody Production by Type (2017-2028)
5.3.2 World CEACAM1Antibody Production Value by Type (2017-2028)
5.3.3 World CEACAM1Antibody Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World CEACAM1Antibody Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Flow Cytometry
6.2.2 ELISA
6.2.3 Western Blot
6.2.4 Immunoprecipitation
6.2.5 Immunofluorescence
6.2.6 Other
6.3 Market Segment by Application
6.3.1 World CEACAM1Antibody Production by Application (2017-2028)
6.3.2 World CEACAM1Antibody Production Value by Application (2017-2028)
6.3.3 World CEACAM1Antibody Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 Sino Biological, Inc.
7.1.1 Sino Biological, Inc. Details
7.1.2 Sino Biological, Inc. Major Business
7.1.3 Sino Biological, Inc. CEACAM1Antibody Product and Services
7.1.4 Sino Biological, Inc. CEACAM1Antibody Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 Sino Biological, Inc. Recent Developments/Updates
7.1.6 Sino Biological, Inc. Competitive Strengths & Weaknesses
7.2 ??Abcam
7.2.1 ??Abcam Details
7.2.2 ??Abcam Major Business
7.2.3 ??Abcam CEACAM1Antibody Product and Services
7.2.4 ??Abcam CEACAM1Antibody Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 ??Abcam Recent Developments/Updates
7.2.6 ??Abcam Competitive Strengths & Weaknesses
7.3 Thermo Fisher Scientific (China) Co., Ltd.
7.3.1 Thermo Fisher Scientific (China) Co., Ltd. Details
7.3.2 Thermo Fisher Scientific (China) Co., Ltd. Major Business
7.3.3 Thermo Fisher Scientific (China) Co., Ltd. CEACAM1Antibody Product and Services
7.3.4 Thermo Fisher Scientific (China) Co., Ltd. CEACAM1Antibody Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 Thermo Fisher Scientific (China) Co., Ltd. Recent Developments/Updates
7.3.6 Thermo Fisher Scientific (China) Co., Ltd. Competitive Strengths & Weaknesses
7.4 Bio-Techne
7.4.1 Bio-Techne Details
7.4.2 Bio-Techne Major Business
7.4.3 Bio-Techne CEACAM1Antibody Product and Services
7.4.4 Bio-Techne CEACAM1Antibody Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Bio-Techne Recent Developments/Updates
7.4.6 Bio-Techne Competitive Strengths & Weaknesses
7.5 BioLegend
7.5.1 BioLegend Details
7.5.2 BioLegend Major Business
7.5.3 BioLegend CEACAM1Antibody Product and Services
7.5.4 BioLegend CEACAM1Antibody Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 BioLegend Recent Developments/Updates
7.5.6 BioLegend Competitive Strengths & Weaknesses
7.6 LifeSpan BioSciences, Inc
7.6.1 LifeSpan BioSciences, Inc Details
7.6.2 LifeSpan BioSciences, Inc Major Business
7.6.3 LifeSpan BioSciences, Inc CEACAM1Antibody Product and Services
7.6.4 LifeSpan BioSciences, Inc CEACAM1Antibody Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 LifeSpan BioSciences, Inc Recent Developments/Updates
7.6.6 LifeSpan BioSciences, Inc Competitive Strengths & Weaknesses
7.7 Elabscience Biotechnology Inc.
7.7.1 Elabscience Biotechnology Inc. Details
7.7.2 Elabscience Biotechnology Inc. Major Business
7.7.3 Elabscience Biotechnology Inc. CEACAM1Antibody Product and Services
7.7.4 Elabscience Biotechnology Inc. CEACAM1Antibody Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 Elabscience Biotechnology Inc. Recent Developments/Updates
7.7.6 Elabscience Biotechnology Inc. Competitive Strengths & Weaknesses
7.8 Boster Biological Technology
7.8.1 Boster Biological Technology Details
7.8.2 Boster Biological Technology Major Business
7.8.3 Boster Biological Technology CEACAM1Antibody Product and Services
7.8.4 Boster Biological Technology CEACAM1Antibody Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 Boster Biological Technology Recent Developments/Updates
7.8.6 Boster Biological Technology Competitive Strengths & Weaknesses
7.9 Merck
7.9.1 Merck Details
7.9.2 Merck Major Business
7.9.3 Merck CEACAM1Antibody Product and Services
7.9.4 Merck CEACAM1Antibody Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.9.5 Merck Recent Developments/Updates
7.9.6 Merck Competitive Strengths & Weaknesses
7.10 Wuhan Fine Biotech Co., Ltd.
7.10.1 Wuhan Fine Biotech Co., Ltd. Details
7.10.2 Wuhan Fine Biotech Co., Ltd. Major Business
7.10.3 Wuhan Fine Biotech Co., Ltd. CEACAM1Antibody Product and Services
7.10.4 Wuhan Fine Biotech Co., Ltd. CEACAM1Antibody Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.10.5 Wuhan Fine Biotech Co., Ltd. Recent Developments/Updates
7.10.6 Wuhan Fine Biotech Co., Ltd. Competitive Strengths & Weaknesses
7.11 ProSci Incorporated
7.11.1 ProSci Incorporated Details
7.11.2 ProSci Incorporated Major Business
7.11.3 ProSci Incorporated CEACAM1Antibody Product and Services
7.11.4 ProSci Incorporated CEACAM1Antibody Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.11.5 ProSci Incorporated Recent Developments/Updates
7.11.6 ProSci Incorporated Competitive Strengths & Weaknesses
7.12 Abbexa
7.12.1 Abbexa Details
7.12.2 Abbexa Major Business
7.12.3 Abbexa CEACAM1Antibody Product and Services
7.12.4 Abbexa CEACAM1Antibody Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.12.5 Abbexa Recent Developments/Updates
7.12.6 Abbexa Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of CEACAM1Antibody and Key Manufacturers
8.2 CEACAM1Antibody Manufacturing Costs
8.3 CEACAM1Antibody Production Process
8.4 CEACAM1Antibody Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for CEACAM1Antibody Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 CEACAM1Antibody Typical Distributors
9.3 CEACAM1Antibody Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
LIST OF TABLES
Table 1. World CEACAM1Antibody Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World CEACAM1Antibody Production Value by Region (2017-2022) & (USD Million)
Table 3. World CEACAM1Antibody Production Value by Region (2023-2028) & (USD Million)
Table 4. World CEACAM1Antibody Production Value Market Share by Region (2017-2022)
Table 5. World CEACAM1Antibody Production Value Market Share by Region (2023-2028)
Table 6. World CEACAM1Antibody Production by Region (2017-2022) & (K Units)
Table 7. World CEACAM1Antibody Production by Region (2023-2028) & (K Units)
Table 8. World CEACAM1Antibody Production Market Share by Region (2017-2022)
Table 9. World CEACAM1Antibody Production Market Share by Region (2023-2028)
Table 10. World CEACAM1Antibody Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World CEACAM1Antibody Average Price by Region (2023-2028) & (US$/Unit)
Table 12. CEACAM1Antibody Major Market Trends
Table 13. World CEACAM1Antibody Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World CEACAM1Antibody Consumption by Region (2017-2022) & (K Units)
Table 15. World CEACAM1Antibody Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World CEACAM1Antibody Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key CEACAM1Antibody Producers in 2021
Table 18. World CEACAM1Antibody Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key CEACAM1Antibody Producers in 2021
Table 20. World CEACAM1Antibody Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global CEACAM1Antibody Company Evaluation Quadrant
Table 22. World CEACAM1Antibody Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and CEACAM1Antibody Production Site of Key Manufacturer
Table 24. CEACAM1Antibody Market: Company Product Type Footprint
Table 25. CEACAM1Antibody Market: Company Product Application Footprint
Table 26. CEACAM1Antibody Competitive Factors
Table 27. CEACAM1Antibody New Entrant and Capacity Expansion Plans
Table 28. CEACAM1Antibody Mergers & Acquisitions Activity
Table 29. United States VS China CEACAM1Antibody Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China CEACAM1Antibody Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China CEACAM1Antibody Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of CEACAM1Antibody in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States CEACAM1Antibody Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States CEACAM1Antibody Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States CEACAM1Antibody Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States CEACAM1Antibody Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of CEACAM1Antibody in China, Company Headquarters and Production Place (Province, Country)
Table 38. China CEACAM1Antibody Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China CEACAM1Antibody Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China CEACAM1Antibody Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China CEACAM1Antibody Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of CEACAM1Antibody in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World CEACAM1Antibody Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World CEACAM1Antibody Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World CEACAM1Antibody Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World CEACAM1Antibody Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World CEACAM1Antibody Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World CEACAM1Antibody Production by Type (2017-2022) & (K Units)
Table 49. World CEACAM1Antibody Production by Type (2023-2028) & (K Units)
Table 50. World CEACAM1Antibody Production Value by Type (2017-2022) & (USD Million)
Table 51. World CEACAM1Antibody Production Value by Type (2023-2028) & (USD Million)
Table 52. World CEACAM1Antibody Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World CEACAM1Antibody Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World CEACAM1Antibody Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World CEACAM1Antibody Production by Application (2017-2022) & (K Units)
Table 56. World CEACAM1Antibody Production by Application (2023-2028) & (K Units)
Table 57. World CEACAM1Antibody Production Value by Application (2017-2022) & (USD Million)
Table 58. World CEACAM1Antibody Production Value by Application (2023-2028) & (USD Million)
Table 59. World CEACAM1Antibody Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World CEACAM1Antibody Average Price by Application (2023-2028) & (US$/Unit)
Table 61. Sino Biological, Inc. Basic Information, Manufacturing Base and Competitors
Table 62. Sino Biological, Inc. Major Business
Table 63. Sino Biological, Inc. CEACAM1Antibody Product and Services
Table 64. Sino Biological, Inc. CEACAM1Antibody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. Sino Biological, Inc. Recent Developments/Updates
Table 66. Sino Biological, Inc. Competitive Strengths & Weaknesses
Table 67. ??Abcam Basic Information, Manufacturing Base and Competitors
Table 68. ??Abcam Major Business
Table 69. ??Abcam CEACAM1Antibody Product and Services
Table 70. ??Abcam CEACAM1Antibody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. ??Abcam Recent Developments/Updates
Table 72. ??Abcam Competitive Strengths & Weaknesses
Table 73. Thermo Fisher Scientific (China) Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 74. Thermo Fisher Scientific (China) Co., Ltd. Major Business
Table 75. Thermo Fisher Scientific (China) Co., Ltd. CEACAM1Antibody Product and Services
Table 76. Thermo Fisher Scientific (China) Co., Ltd. CEACAM1Antibody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Thermo Fisher Scientific (China) Co., Ltd. Recent Developments/Updates
Table 78. Thermo Fisher Scientific (China) Co., Ltd. Competitive Strengths & Weaknesses
Table 79. Bio-Techne Basic Information, Manufacturing Base and Competitors
Table 80. Bio-Techne Major Business
Table 81. Bio-Techne CEACAM1Antibody Product and Services
Table 82. Bio-Techne CEACAM1Antibody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Bio-Techne Recent Developments/Updates
Table 84. Bio-Techne Competitive Strengths & Weaknesses
Table 85. BioLegend Basic Information, Manufacturing Base and Competitors
Table 86. BioLegend Major Business
Table 87. BioLegend CEACAM1Antibody Product and Services
Table 88. BioLegend CEACAM1Antibody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. BioLegend Recent Developments/Updates
Table 90. BioLegend Competitive Strengths & Weaknesses
Table 91. LifeSpan BioSciences, Inc Basic Information, Manufacturing Base and Competitors
Table 92. LifeSpan BioSciences, Inc Major Business
Table 93. LifeSpan BioSciences, Inc CEACAM1Antibody Product and Services
Table 94. LifeSpan BioSciences, Inc CEACAM1Antibody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. LifeSpan BioSciences, Inc Recent Developments/Updates
Table 96. LifeSpan BioSciences, Inc Competitive Strengths & Weaknesses
Table 97. Elabscience Biotechnology Inc. Basic Information, Manufacturing Base and Competitors
Table 98. Elabscience Biotechnology Inc. Major Business
Table 99. Elabscience Biotechnology Inc. CEACAM1Antibody Product and Services
Table 100. Elabscience Biotechnology Inc. CEACAM1Antibody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. Elabscience Biotechnology Inc. Recent Developments/Updates
Table 102. Elabscience Biotechnology Inc. Competitive Strengths & Weaknesses
Table 103. Boster Biological Technology Basic Information, Manufacturing Base and Competitors
Table 104. Boster Biological Technology Major Business
Table 105. Boster Biological Technology CEACAM1Antibody Product and Services
Table 106. Boster Biological Technology CEACAM1Antibody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. Boster Biological Technology Recent Developments/Updates
Table 108. Boster Biological Technology Competitive Strengths & Weaknesses
Table 109. Merck Basic Information, Manufacturing Base and Competitors
Table 110. Merck Major Business
Table 111. Merck CEACAM1Antibody Product and Services
Table 112. Merck CEACAM1Antibody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 113. Merck Recent Developments/Updates
Table 114. Merck Competitive Strengths & Weaknesses
Table 115. Wuhan Fine Biotech Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 116. Wuhan Fine Biotech Co., Ltd. Major Business
Table 117. Wuhan Fine Biotech Co., Ltd. CEACAM1Antibody Product and Services
Table 118. Wuhan Fine Biotech Co., Ltd. CEACAM1Antibody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 119. Wuhan Fine Biotech Co., Ltd. Recent Developments/Updates
Table 120. Wuhan Fine Biotech Co., Ltd. Competitive Strengths & Weaknesses
Table 121. ProSci Incorporated Basic Information, Manufacturing Base and Competitors
Table 122. ProSci Incorporated Major Business
Table 123. ProSci Incorporated CEACAM1Antibody Product and Services
Table 124. ProSci Incorporated CEACAM1Antibody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 125. ProSci Incorporated Recent Developments/Updates
Table 126. Abbexa Basic Information, Manufacturing Base and Competitors
Table 127. Abbexa Major Business
Table 128. Abbexa CEACAM1Antibody Product and Services
Table 129. Abbexa CEACAM1Antibody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 130. CEACAM1Antibody Raw Material
Table 131. Key Manufacturers of CEACAM1Antibody Raw Materials
Table 132. CEACAM1Antibody Typical Distributors
Table 133. CEACAM1Antibody Typical Customers
Table 1. World CEACAM1Antibody Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World CEACAM1Antibody Production Value by Region (2017-2022) & (USD Million)
Table 3. World CEACAM1Antibody Production Value by Region (2023-2028) & (USD Million)
Table 4. World CEACAM1Antibody Production Value Market Share by Region (2017-2022)
Table 5. World CEACAM1Antibody Production Value Market Share by Region (2023-2028)
Table 6. World CEACAM1Antibody Production by Region (2017-2022) & (K Units)
Table 7. World CEACAM1Antibody Production by Region (2023-2028) & (K Units)
Table 8. World CEACAM1Antibody Production Market Share by Region (2017-2022)
Table 9. World CEACAM1Antibody Production Market Share by Region (2023-2028)
Table 10. World CEACAM1Antibody Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World CEACAM1Antibody Average Price by Region (2023-2028) & (US$/Unit)
Table 12. CEACAM1Antibody Major Market Trends
Table 13. World CEACAM1Antibody Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World CEACAM1Antibody Consumption by Region (2017-2022) & (K Units)
Table 15. World CEACAM1Antibody Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World CEACAM1Antibody Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key CEACAM1Antibody Producers in 2021
Table 18. World CEACAM1Antibody Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key CEACAM1Antibody Producers in 2021
Table 20. World CEACAM1Antibody Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global CEACAM1Antibody Company Evaluation Quadrant
Table 22. World CEACAM1Antibody Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and CEACAM1Antibody Production Site of Key Manufacturer
Table 24. CEACAM1Antibody Market: Company Product Type Footprint
Table 25. CEACAM1Antibody Market: Company Product Application Footprint
Table 26. CEACAM1Antibody Competitive Factors
Table 27. CEACAM1Antibody New Entrant and Capacity Expansion Plans
Table 28. CEACAM1Antibody Mergers & Acquisitions Activity
Table 29. United States VS China CEACAM1Antibody Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China CEACAM1Antibody Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China CEACAM1Antibody Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of CEACAM1Antibody in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States CEACAM1Antibody Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States CEACAM1Antibody Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States CEACAM1Antibody Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States CEACAM1Antibody Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of CEACAM1Antibody in China, Company Headquarters and Production Place (Province, Country)
Table 38. China CEACAM1Antibody Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China CEACAM1Antibody Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China CEACAM1Antibody Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China CEACAM1Antibody Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of CEACAM1Antibody in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World CEACAM1Antibody Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World CEACAM1Antibody Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World CEACAM1Antibody Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World CEACAM1Antibody Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World CEACAM1Antibody Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World CEACAM1Antibody Production by Type (2017-2022) & (K Units)
Table 49. World CEACAM1Antibody Production by Type (2023-2028) & (K Units)
Table 50. World CEACAM1Antibody Production Value by Type (2017-2022) & (USD Million)
Table 51. World CEACAM1Antibody Production Value by Type (2023-2028) & (USD Million)
Table 52. World CEACAM1Antibody Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World CEACAM1Antibody Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World CEACAM1Antibody Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World CEACAM1Antibody Production by Application (2017-2022) & (K Units)
Table 56. World CEACAM1Antibody Production by Application (2023-2028) & (K Units)
Table 57. World CEACAM1Antibody Production Value by Application (2017-2022) & (USD Million)
Table 58. World CEACAM1Antibody Production Value by Application (2023-2028) & (USD Million)
Table 59. World CEACAM1Antibody Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World CEACAM1Antibody Average Price by Application (2023-2028) & (US$/Unit)
Table 61. Sino Biological, Inc. Basic Information, Manufacturing Base and Competitors
Table 62. Sino Biological, Inc. Major Business
Table 63. Sino Biological, Inc. CEACAM1Antibody Product and Services
Table 64. Sino Biological, Inc. CEACAM1Antibody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. Sino Biological, Inc. Recent Developments/Updates
Table 66. Sino Biological, Inc. Competitive Strengths & Weaknesses
Table 67. ??Abcam Basic Information, Manufacturing Base and Competitors
Table 68. ??Abcam Major Business
Table 69. ??Abcam CEACAM1Antibody Product and Services
Table 70. ??Abcam CEACAM1Antibody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. ??Abcam Recent Developments/Updates
Table 72. ??Abcam Competitive Strengths & Weaknesses
Table 73. Thermo Fisher Scientific (China) Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 74. Thermo Fisher Scientific (China) Co., Ltd. Major Business
Table 75. Thermo Fisher Scientific (China) Co., Ltd. CEACAM1Antibody Product and Services
Table 76. Thermo Fisher Scientific (China) Co., Ltd. CEACAM1Antibody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Thermo Fisher Scientific (China) Co., Ltd. Recent Developments/Updates
Table 78. Thermo Fisher Scientific (China) Co., Ltd. Competitive Strengths & Weaknesses
Table 79. Bio-Techne Basic Information, Manufacturing Base and Competitors
Table 80. Bio-Techne Major Business
Table 81. Bio-Techne CEACAM1Antibody Product and Services
Table 82. Bio-Techne CEACAM1Antibody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Bio-Techne Recent Developments/Updates
Table 84. Bio-Techne Competitive Strengths & Weaknesses
Table 85. BioLegend Basic Information, Manufacturing Base and Competitors
Table 86. BioLegend Major Business
Table 87. BioLegend CEACAM1Antibody Product and Services
Table 88. BioLegend CEACAM1Antibody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. BioLegend Recent Developments/Updates
Table 90. BioLegend Competitive Strengths & Weaknesses
Table 91. LifeSpan BioSciences, Inc Basic Information, Manufacturing Base and Competitors
Table 92. LifeSpan BioSciences, Inc Major Business
Table 93. LifeSpan BioSciences, Inc CEACAM1Antibody Product and Services
Table 94. LifeSpan BioSciences, Inc CEACAM1Antibody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. LifeSpan BioSciences, Inc Recent Developments/Updates
Table 96. LifeSpan BioSciences, Inc Competitive Strengths & Weaknesses
Table 97. Elabscience Biotechnology Inc. Basic Information, Manufacturing Base and Competitors
Table 98. Elabscience Biotechnology Inc. Major Business
Table 99. Elabscience Biotechnology Inc. CEACAM1Antibody Product and Services
Table 100. Elabscience Biotechnology Inc. CEACAM1Antibody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. Elabscience Biotechnology Inc. Recent Developments/Updates
Table 102. Elabscience Biotechnology Inc. Competitive Strengths & Weaknesses
Table 103. Boster Biological Technology Basic Information, Manufacturing Base and Competitors
Table 104. Boster Biological Technology Major Business
Table 105. Boster Biological Technology CEACAM1Antibody Product and Services
Table 106. Boster Biological Technology CEACAM1Antibody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. Boster Biological Technology Recent Developments/Updates
Table 108. Boster Biological Technology Competitive Strengths & Weaknesses
Table 109. Merck Basic Information, Manufacturing Base and Competitors
Table 110. Merck Major Business
Table 111. Merck CEACAM1Antibody Product and Services
Table 112. Merck CEACAM1Antibody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 113. Merck Recent Developments/Updates
Table 114. Merck Competitive Strengths & Weaknesses
Table 115. Wuhan Fine Biotech Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 116. Wuhan Fine Biotech Co., Ltd. Major Business
Table 117. Wuhan Fine Biotech Co., Ltd. CEACAM1Antibody Product and Services
Table 118. Wuhan Fine Biotech Co., Ltd. CEACAM1Antibody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 119. Wuhan Fine Biotech Co., Ltd. Recent Developments/Updates
Table 120. Wuhan Fine Biotech Co., Ltd. Competitive Strengths & Weaknesses
Table 121. ProSci Incorporated Basic Information, Manufacturing Base and Competitors
Table 122. ProSci Incorporated Major Business
Table 123. ProSci Incorporated CEACAM1Antibody Product and Services
Table 124. ProSci Incorporated CEACAM1Antibody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 125. ProSci Incorporated Recent Developments/Updates
Table 126. Abbexa Basic Information, Manufacturing Base and Competitors
Table 127. Abbexa Major Business
Table 128. Abbexa CEACAM1Antibody Product and Services
Table 129. Abbexa CEACAM1Antibody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 130. CEACAM1Antibody Raw Material
Table 131. Key Manufacturers of CEACAM1Antibody Raw Materials
Table 132. CEACAM1Antibody Typical Distributors
Table 133. CEACAM1Antibody Typical Customers
LIST OF FIGURES
Figure 1. CEACAM1Antibody Picture
Figure 2. World CEACAM1Antibody Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World CEACAM1Antibody Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World CEACAM1Antibody Production (2017-2028) & (K Units)
Figure 5. World CEACAM1Antibody Average Price (2017-2028) & (US$/Unit)
Figure 6. World CEACAM1Antibody Production Value Market Share by Region (2017-2028)
Figure 7. World CEACAM1Antibody Production Market Share by Region (2017-2028)
Figure 8. North America CEACAM1Antibody Production (2017-2028) & (K Units)
Figure 9. Europe CEACAM1Antibody Production (2017-2028) & (K Units)
Figure 10. China CEACAM1Antibody Production (2017-2028) & (K Units)
Figure 11. Japan CEACAM1Antibody Production (2017-2028) & (K Units)
Figure 12. CEACAM1Antibody Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World CEACAM1Antibody Demand (2017-2028) & (K Units)
Figure 15. World CEACAM1Antibody Consumption Market Share by Region (2017-2028)
Figure 16. United States CEACAM1Antibody Consumption (2017-2028) & (K Units)
Figure 17. China CEACAM1Antibody Consumption (2017-2028) & (K Units)
Figure 18. Europe CEACAM1Antibody Consumption (2017-2028) & (K Units)
Figure 19. Japan CEACAM1Antibody Consumption (2017-2028) & (K Units)
Figure 20. South Korea CEACAM1Antibody Consumption (2017-2028) & (K Units)
Figure 21. ASEAN CEACAM1Antibody Consumption (2017-2028) & (K Units)
Figure 22. India CEACAM1Antibody Consumption (2017-2028) & (K Units)
Figure 23. Producer Shipments of CEACAM1Antibody by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for CEACAM1Antibody Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for CEACAM1Antibody Markets in 2021
Figure 26. United States VS China: CEACAM1Antibody Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: CEACAM1Antibody Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: CEACAM1Antibody Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of CEACAM1Antibody in United States
Figure 30. Key Producers and Market Share of CEACAM1Antibody in China
Figure 31. Key Producers and Market Share of CEACAM1Antibody in Rest of World
Figure 32. World CEACAM1Antibody Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World CEACAM1Antibody Production Value Market Share by Type in 2021
Figure 34. Monoclonal Antibody
Figure 35. Polyclonal Antibody
Figure 36. World CEACAM1Antibody Production Market Share by Type (2017-2028)
Figure 37. World CEACAM1Antibody Production Value Market Share by Type (2017-2028)
Figure 38. World CEACAM1Antibody Average Price by Type (2017-2028) & (US$/Unit)
Figure 39. World CEACAM1Antibody Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 40. World CEACAM1Antibody Production Value Market Share by Application in 2021
Figure 41. Flow Cytometry
Figure 42. ELISA
Figure 43. Western Blot
Figure 44. Immunoprecipitation
Figure 45. Immunofluorescence
Figure 46. Other
Figure 47. World CEACAM1Antibody Production Market Share by Application (2017-2028)
Figure 48. World CEACAM1Antibody Production Value Market Share by Application (2017-2028)
Figure 49. World CEACAM1Antibody Average Price by Application (2017-2028) & (US$/Unit)
Figure 50. Manufacturing Cost Structure Analysis of CEACAM1Antibody in 2021
Figure 51. Manufacturing Process Analysis of CEACAM1Antibody
Figure 52. CEACAM1Antibody Industrial Chain
Figure 53. Distribution Channel Breakdown for CEACAM1Antibody Shipments (%): 2017-2028
Figure 54. Direct Channel Pros & Cons
Figure 55. Indirect Channel Pros & Cons
Figure 56. Methodology
Figure 57. Research Process and Data Source
Figure 1. CEACAM1Antibody Picture
Figure 2. World CEACAM1Antibody Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World CEACAM1Antibody Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World CEACAM1Antibody Production (2017-2028) & (K Units)
Figure 5. World CEACAM1Antibody Average Price (2017-2028) & (US$/Unit)
Figure 6. World CEACAM1Antibody Production Value Market Share by Region (2017-2028)
Figure 7. World CEACAM1Antibody Production Market Share by Region (2017-2028)
Figure 8. North America CEACAM1Antibody Production (2017-2028) & (K Units)
Figure 9. Europe CEACAM1Antibody Production (2017-2028) & (K Units)
Figure 10. China CEACAM1Antibody Production (2017-2028) & (K Units)
Figure 11. Japan CEACAM1Antibody Production (2017-2028) & (K Units)
Figure 12. CEACAM1Antibody Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World CEACAM1Antibody Demand (2017-2028) & (K Units)
Figure 15. World CEACAM1Antibody Consumption Market Share by Region (2017-2028)
Figure 16. United States CEACAM1Antibody Consumption (2017-2028) & (K Units)
Figure 17. China CEACAM1Antibody Consumption (2017-2028) & (K Units)
Figure 18. Europe CEACAM1Antibody Consumption (2017-2028) & (K Units)
Figure 19. Japan CEACAM1Antibody Consumption (2017-2028) & (K Units)
Figure 20. South Korea CEACAM1Antibody Consumption (2017-2028) & (K Units)
Figure 21. ASEAN CEACAM1Antibody Consumption (2017-2028) & (K Units)
Figure 22. India CEACAM1Antibody Consumption (2017-2028) & (K Units)
Figure 23. Producer Shipments of CEACAM1Antibody by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for CEACAM1Antibody Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for CEACAM1Antibody Markets in 2021
Figure 26. United States VS China: CEACAM1Antibody Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: CEACAM1Antibody Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: CEACAM1Antibody Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of CEACAM1Antibody in United States
Figure 30. Key Producers and Market Share of CEACAM1Antibody in China
Figure 31. Key Producers and Market Share of CEACAM1Antibody in Rest of World
Figure 32. World CEACAM1Antibody Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World CEACAM1Antibody Production Value Market Share by Type in 2021
Figure 34. Monoclonal Antibody
Figure 35. Polyclonal Antibody
Figure 36. World CEACAM1Antibody Production Market Share by Type (2017-2028)
Figure 37. World CEACAM1Antibody Production Value Market Share by Type (2017-2028)
Figure 38. World CEACAM1Antibody Average Price by Type (2017-2028) & (US$/Unit)
Figure 39. World CEACAM1Antibody Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 40. World CEACAM1Antibody Production Value Market Share by Application in 2021
Figure 41. Flow Cytometry
Figure 42. ELISA
Figure 43. Western Blot
Figure 44. Immunoprecipitation
Figure 45. Immunofluorescence
Figure 46. Other
Figure 47. World CEACAM1Antibody Production Market Share by Application (2017-2028)
Figure 48. World CEACAM1Antibody Production Value Market Share by Application (2017-2028)
Figure 49. World CEACAM1Antibody Average Price by Application (2017-2028) & (US$/Unit)
Figure 50. Manufacturing Cost Structure Analysis of CEACAM1Antibody in 2021
Figure 51. Manufacturing Process Analysis of CEACAM1Antibody
Figure 52. CEACAM1Antibody Industrial Chain
Figure 53. Distribution Channel Breakdown for CEACAM1Antibody Shipments (%): 2017-2028
Figure 54. Direct Channel Pros & Cons
Figure 55. Indirect Channel Pros & Cons
Figure 56. Methodology
Figure 57. Research Process and Data Source
